Even minor mistakes could lead to serious consequences
Protocol 2: significant weight loss (20-25% body weight) Goal: Substantial weight reduction for health improvement Tirzepatide approach: Full escalation to 10-15 mg Expect to reach target dose by week 17-21 Weight loss at 15 mg: approximately 22.5% at 72 weeks Plateau typically occurs around weeks 60-72 Retatrutide approach: Full escalation to 8-12 mg Expect to reach target dose by week 13-17 Weight loss at 12 mg: 24.2% at 48 weeks, 28.7% at 68 weeks No plateau observed in trial data at 48 or 68 weeks For significant weight loss goals, retatrutide reaches 20%+ body weight reduction faster and ultimately achieves a higher ceiling
If a reader clicks an affiliate link in this article and subsequently makes a purchase from altRx, the publisher may earn a commission at no additional cost to the reader
4 Reddit Questions About GLP-1s, Answered by Obesity Experts People frequently turn to Reddit to ask questions and share advice about taking glucagon-like peptide-1 (GLP-1) medication to manage obesity
prescriptions are filled by Provns partner state-licensed compounding pharmacies and shipped with refrigeration controls directly to your US address Ongoing care virtual follow up visits for dose adjustments, safety monitoring, and weight management support If youre comparing semaglutide vs tirzepatide, your Provn provider can help you decide which medication fits your treatment plan based on your health profile
A patient can finish a course of GLP-1 treatment significantly lighter and simultaneously in a weaker metabolic position than when they started if muscle preservation was not part of the plan. This is the mechanism behind what clinicians commonly observe in weight cycling